In part 8, the conclusion of this Exclusive Interview, Jamie Uribarri talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA about kidney disease prevention through preventing the development of type 2 diabetes.

The SGLT-2 inhibitors continue to garner headlines and scientific publications as our knowledge of how they work and what they can do increases. Part of the reason all this is happening at a rapid pace is the multiple brands available on the class. This means that endpoint studies can be …

The pressures of reimbursement have taken their affect on the amount of time that a patient gets to spend with their clinician. This means that often there is no time for you to say everything to your patient that you would like to and that means that the obesity conversation …

In this week's Homerun Slides, the conclusion of the framework for understanding diabetes focuses on appropriate medication according to patient need.

OSA and beta-cell function: While the impact of OSA in IR has been studied extensively, the impact of OSA on beta-cell function has received little attention, despite being an essential part of the pathogenesis of T2DM and prediabetes. A small number of animal studies showed that intermittent hypoxia increases beta-cell death, and results in beta-cell dysfunction, although the intermittent hypoxia used in this study is far greater than that which occurs in humans with OSA.

Many years ago, when Steve and I were first sending our newsletter to a few pharmacists, we realized we needed to offer more than any other diabetes newsletter. We were the new kids on the block; we weren’t journalists, but we were pharmacists. So we started to look for well-respected, …

Study shows importance of clinical consciousness and assistance with disease management in individuals who were diagnosed with type 2 diabetes prior to age 45.

Patch delivery system shows promise as a new developing treatment option for diabetes.

Low Fat-Vegetarian-Vegan diet shown to improve glucose control, slow diabetes progression.

New technology allows freedom from daily manual injections and oral antidiabetics.